{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:27Z","timestamp":1791544227779,"version":"4.3.4"},"reference-count":177,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with poor prognosis, early recurrence, and the lack of durable chemotherapy responses and specific targeted treatments. The recent FDA approval for immune checkpoint inhibition in combination with nab-paclitaxel for the treatment of metastatic TNBC created opportunity to advocate for immunotherapy in TNBC patients. However, improving the current low response rates is vital. Most cancers, including TNBC tumors, display metabolic plasticity and undergo reprogramming into highly glycolytic tumors through the Warburg effect. Consequently, accumulation of the metabolic byproduct lactate and extracellular acidification is often observed in several solid tumors, thereby exacerbating tumor cell proliferation, metastasis, and angiogenesis. In this review, we focus on the role of lactate acidosis in the microenvironment of glycolytic breast tumors as a major driver for immune evasion with a special emphasis on TNBCs. In particular, we will discuss the role of lactate regulators such as glucose transporters, lactate dehydrogenases, and lactate transporters in modulating immune functionality and checkpoint expression in numerous immune cell types. This review aims to spark discussion on interventions targeting lactate acidosis in combination with immunotherapy to provide an effective means of improving response to immune checkpoint inhibitors in TNBC, in addition to highlighting challenges that may arise from TNBC tumor heterogeneity.<\/jats:p>","DOI":"10.3389\/fonc.2020.598626","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T04:27:54Z","timestamp":1606364874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors"],"prefix":"10.3389","volume":"10","author":[{"given":"Adviti","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Decock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124964","article-title":"Breast cancer intrinsic subtype classification, clinical use and future trends","volume":"5","author":"Dai","year":"2015","journal-title":"Am J Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16938","article-title":"Triple negative breast cancer: the kiss of death","volume":"8","author":"Jitariu","year":"2017","journal-title":"Oncotarget"},{"key":"B3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge","volume":"8","author":"Nedeljkovic","year":"2019","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","article-title":"Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies","volume":"35","author":"Jiang","year":"2019","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.06.016","article-title":"Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer","author":"Gaynor","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00730-0","article-title":"Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer","volume":"15","author":"Michel","year":"2020","journal-title":"Target Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.01.011","article-title":"A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer","volume":"11","author":"Liu","year":"2018","journal-title":"Trans Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv192","article-title":"PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes","volume":"26","author":"Ali","year":"2015","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-019-1326-5","article-title":"Recent advances in triple negative breast cancer: the immunotherapy era","volume":"17","author":"Marra","year":"2019","journal-title":"BMC Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy473","article-title":"Passion for immune checkpoint blockade in triple negative breast cancer: Comment on the IMpassion130 study","volume":"30","author":"Kok","year":"2019","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10911-013-9310-8","article-title":"Biology of glucose transport in the mammary gland","volume":"19","author":"Zhao","year":"2014","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-030419-033556","article-title":"Lactate and Acidity in the Cancer Microenvironment","volume":"4","author":"Parks","year":"2020","journal-title":"Annu Rev Cancer Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells8020089","article-title":"Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications","volume":"8","author":"Gandhi","year":"2019","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0889","article-title":"MYC-induced cancer cell energy metabolism and therapeutic opportunities","volume":"15","author":"Dang","year":"2009","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2013.12.025","article-title":"Tumor suppressor p53 and its mutants in cancer metabolism","volume":"356","author":"Liu","year":"2015","journal-title":"Cancer Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.01.002","article-title":"Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects","volume":"1864","author":"Guha","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13058-014-0434-6","article-title":"Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential","volume":"16","author":"Pelicano","year":"2014","journal-title":"Breast Cancer Res: BCR"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068348","article-title":"Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1alpha","volume":"8","author":"Diers","year":"2013","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2014.07.050","article-title":"Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome","volume":"451","author":"Doyen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1098","article-title":"An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer","volume":"72","author":"McCleland","year":"2012","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.11256","article-title":"Glut-1 Expression Correlates with Basal-like Breast Cancer","volume":"4","author":"Hussein","year":"2011","journal-title":"Trans Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000339513","article-title":"Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry","volume":"80","author":"Choi","year":"2013","journal-title":"Pathobiol: J Immunopathol Mol Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5483\/bmbrep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.360","article-title":"Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis","volume":"113","author":"Wilde","year":"2015","journal-title":"Br J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.01.035","article-title":"AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1","volume":"49","author":"Wu","year":"2013","journal-title":"Mol Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501555112","article-title":"Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP","volume":"112","author":"Shen","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0557","article-title":"Absence of TXNIP in Humans Leads to Lactic Acidosis and Low Serum Methionine Linked to Deficient Respiration on Pyruvate","volume":"68","author":"Katsu-Jimenez","year":"2019","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605287","article-title":"BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression","volume":"101","author":"Yan","year":"2009","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-18-0345","article-title":"Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes","volume":"16","author":"Ye","year":"2018","journal-title":"Mol Cancer Res: MCR"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3018","article-title":"High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis","volume":"78","author":"Avanzato","year":"2018","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.3390\/ijms21082947","article-title":"Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer","volume":"21","author":"Lin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/cancers11060750","article-title":"Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment","volume":"11","author":"Mishra","year":"2019","journal-title":"Cancers"},{"key":"B38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2164\/jandrol.109.008367","article-title":"LDHC: the ultimate testis-specific gene","volume":"31","author":"Goldberg","year":"2010","journal-title":"J Androl"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24246","article-title":"An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.breast.2016.08.014","article-title":"High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer","volume":"30","author":"Huang","year":"2016","journal-title":"Breast"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1038\/s41598-017-06378-7","article-title":"Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis","volume":"7","author":"Dong","year":"2017","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3300","article-title":"Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors","volume":"19","author":"Rizwan","year":"2013","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0623","article-title":"Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer","volume":"19","author":"Dennison","year":"2013","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.08.005","article-title":"Lactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer","volume":"30","author":"Brisson","year":"2016","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004180","article-title":"Double genetic disruption of lactate dehydrogenases A and B is required to ablate the \u201cWarburg effect\u201d restricting tumor growth to oxidative metabolism","volume":"293","author":"Zdralevic","year":"2018","journal-title":"J Biol Chem"},{"key":"B46","article-title":"Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer","volume":"62","author":"Koslowski","year":"2002","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02480-4","article-title":"Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy","volume":"69","author":"Thomas","year":"2020","journal-title":"Cancer Immunol Immunother: CII"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.032","article-title":"Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer","volume":"503","author":"Cui","year":"2020","journal-title":"Clin Chimica Acta Int J Clin Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.4963","article-title":"Expression of lactate dehydrogenase C in MDAMB231 cells and its role in tumor invasion and migration","volume":"13","author":"Kong","year":"2016","journal-title":"Mol Med Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.111.091546","article-title":"and energy metabolism in mouse sperm","volume":"85","author":"Odet","year":"2011","journal-title":"Biol Reprod"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2407","article-title":"FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression","volume":"20","author":"Cui","year":"2014","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0886-7","article-title":"Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy","volume":"123","author":"Cheung","year":"2020","journal-title":"Br J Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00231","article-title":"Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy","volume":"10","author":"Baltazar","year":"2020","journal-title":"Front Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/bcr3472","article-title":"Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype","volume":"15","author":"Choi","year":"2013","journal-title":"Breast Cancer Res: BCR"},{"key":"B57","article-title":"Expression of metabolism-related proteins in triple-negative breast cancer","volume":"7","author":"Kim","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/path.4562","article-title":"Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival","volume":"237","author":"Baenke","year":"2015","journal-title":"J Pathol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4161\/cc.11.6.19530","article-title":"Using the \u201creverse Warburg effect\u201d to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers","volume":"11","author":"Witkiewicz","year":"2012","journal-title":"Cell Cycle"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.11.15659","article-title":"Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts","volume":"10","author":"Whitaker-Menezes","year":"2011","journal-title":"Cell Cycle"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03560.x","article-title":"Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma","volume":"56","author":"Pinheiro","year":"2010","journal-title":"Histopathology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3910","article-title":"Targeting lactate transport suppresses in vivo breast tumour growth","volume":"6","author":"Morais-Santos","year":"2015","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1816391116","article-title":"Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways","volume":"116","author":"Jia","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3137","article-title":"Adaptation of energy metabolism in breast cancer brain metastases","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"12252","DOI":"10.1038\/s41598-018-29708-9","article-title":"Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer","volume":"8","author":"Romero-Cordoba","year":"2018","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12032-012-0335-4","article-title":"High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients","volume":"30","author":"Zhao","year":"2013","journal-title":"Med Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205342","article-title":"CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer","volume":"71","author":"Liu","year":"2018","journal-title":"J Clin Pathol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0319","article-title":"Cell surface lactate receptor GPR81 is crucial for cancer cell survival","volume":"74","author":"Roland","year":"2014","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.20517\/2394-4722.2018.102","article-title":"Differential expression and function of the endogenous lactate receptor, GPR81, in ER\u03b1-positive\/HER2-positive epithelial vs. post-EMT triple-negative mesenchymal breast cancer cells","volume":"5","author":"Tafur","year":"2019","journal-title":"J Cancer Metastasis Treat"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12286","article-title":"G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165576","article-title":"A lactate-induced Snail\/STAT3 pathway drives GPR81 expression in lung cancer cells","volume":"1866","author":"Xie","year":"2020","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-010-9188-7","article-title":"Immune cell location and function during post-natal mammary gland development","volume":"15","author":"Reed","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.devcel.2015.07.015","article-title":"Adaptive Immune Regulation of Mammary Postnatal Organogenesis","volume":"34","author":"Plaks","year":"2015","journal-title":"Dev Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003244","article-title":"The role of the microenvironment in mammary gland development and cancer","volume":"2","author":"Polyak","year":"2010","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2478","article-title":"EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape","volume":"76","author":"Lim","year":"2016","journal-title":"Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1713","article-title":"Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma","volume":"7","author":"Long","year":"2018","journal-title":"Cancer Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-016-0348-7","article-title":"Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling","volume":"59","author":"Xie","year":"2016","journal-title":"Sci China Life Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01878","article-title":"Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells","volume":"10","author":"Raychaudhuri","year":"2019","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0688-7","article-title":"Lactate modulates CD4(+) T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis","volume":"38","author":"Comito","year":"2019","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902584","article-title":"Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes","volume":"184","author":"Dietl","year":"2010","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.11.7175","article-title":"Tumor-secreted lactic acid promotes IL-23\/IL-17 proinflammatory pathway","volume":"180","author":"Shime","year":"2008","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1\/PD-L1 agents","volume":"1869","author":"Santoni","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2084195","article-title":"Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities","volume":"2019","author":"Feichtinger","year":"2019","journal-title":"J Oncol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12885-020-6668-z","article-title":"Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.8.4670","article-title":"Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells","volume":"174","author":"Cham","year":"2005","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26410","article-title":"Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation","volume":"131","author":"Mendler","year":"2012","journal-title":"Int J Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions","volume":"13","author":"Haas","year":"2015","journal-title":"PLoS Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1126\/sciimmunol.aan4631","article-title":"Suppression of FIP200 and autophagy by tumor-derived lactate promotes naive T cell apoptosis and affects tumor immunity","volume":"2","author":"Xia","year":"2017","journal-title":"Sci Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12964","article-title":"A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6","volume":"107","author":"Tian","year":"2016","journal-title":"Cancer Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30646","article-title":"Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-gamma and induces NK cell-dependent lymphoma control without other immunotherapies","volume":"140","author":"Potzl","year":"2017","journal-title":"Int J Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1901376116","article-title":"Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function","volume":"116","author":"Kumar","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa036","article-title":"Role of dendritic cell metabolic reprogramming in tumor immune evasion","volume":"32","author":"Plebanek","year":"2020","journal-title":"Int Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1307","article-title":"Downregulation of Membrane Trafficking Proteins and Lactate Conditioning Determine Loss of Dendritic Cell Function in Lung Cancer","volume":"78","author":"Caronni","year":"2018","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300772","article-title":"Dendritic cell reprogramming by endogenously produced lactic acid","volume":"191","author":"Nasi","year":"2013","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3468","article-title":"Impaired IFN-alpha production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression","volume":"72","author":"Sisirak","year":"2012","journal-title":"Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e2779","DOI":"10.1038\/cddis.2017.192","article-title":"Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis","volume":"8","author":"Jian","year":"2017","journal-title":"Cell Death Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2177-1","article-title":"mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells","volume":"67","author":"Deng","year":"2018","journal-title":"Cancer Immunol Immunother: CII"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.08.010","article-title":"Tumor-associated macrophages in breast cancer: Innocent bystander or important player","volume":"70","author":"Qiu","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ijms21010157","article-title":"Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response","volume":"21","author":"Cassim","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.humpath.2017.09.001","article-title":"Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer","volume":"69","author":"Klingen","year":"2017","journal-title":"Hum Pathol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jss.2017.09.035","article-title":"Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients","volume":"222","author":"Zhang","year":"2018","journal-title":"J Surg Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.1038\/srep09188","article-title":"Characterization of macrophage\u2013cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer","volume":"5","author":"Hollmen","year":"2015","journal-title":"Sci Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614035114","article-title":"Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"key":"B122","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-018-0860-x","article-title":"Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer","volume":"37","author":"Steenbrugge","year":"2018","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22786","article-title":"Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.01.005","article-title":"Lactic acid delays the inflammatory response of human monocytes","volume":"457","author":"Peter","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1624130","article-title":"A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer","volume":"8","author":"Faucheux","year":"2019","journal-title":"Oncoimmunology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/cancers11020223","article-title":"Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies","volume":"11","author":"Cona","year":"2019","journal-title":"Cancers"},{"key":"B127","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.467","article-title":"Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma","volume":"114","author":"Diem","year":"2016","journal-title":"Br J Cancer"},{"key":"B129","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1674-5","article-title":"VISTA is an acidic pH-selective ligand for PSGL-1","volume":"574","author":"Johnston","year":"2019","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cbic.201900544","article-title":"Small-Molecule Inhibition of Glucose Transporters GLUT-1-4","volume":"21","author":"Reckzeh","year":"2020","journal-title":"Chembiochem: Eur J Chem Biol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/cancers12010154","article-title":"Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds","volume":"12","author":"Barbosa","year":"2020","journal-title":"Cancers"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3928","article-title":"Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death","volume":"72","author":"Cheng","year":"2012","journal-title":"Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4161\/15384047.2014.955992","article-title":"Targeting of two aspects of metabolism in breast cancer treatment","volume":"15","author":"Gang","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01402","article-title":"Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics","volume":"10","author":"Turbitt","year":"2019","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.033","article-title":"Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma","volume":"137","author":"Kim","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/cancers12051153","article-title":"Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence","volume":"12","author":"Mirabile","year":"2020","journal-title":"Cancers"},{"key":"B143","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol Cell"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.08.012","article-title":"Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways","volume":"47","author":"Farabegoli","year":"2012","journal-title":"Eur J Pharm Sci: Off J Eur Fed Pharm Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1038\/s41598-019-40617-3","article-title":"A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B147","doi-asserted-by":"publisher","first-page":"PR06","DOI":"10.1158\/2326-6066.IMM2016-PR06","article-title":"Abstract PR06: Overcoming intratumor T-cell exclusion by modulation of lactate metabolism to improve immune checkpoint therapies in aggressive breast cancer","volume":"4","author":"Zappasodi","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-017-0593-2","article-title":"PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a","volume":"36","author":"Huang","year":"2017","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B149","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cancers11040450","article-title":"Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma","volume":"11","author":"Daneshmandi","year":"2019","journal-title":"Cancers"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1208\/s12248-018-0261-2","article-title":"In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model","volume":"21","author":"Guan","year":"2018","journal-title":"AAPS J"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27712","article-title":"Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model","volume":"132","author":"Chirasani","year":"2013","journal-title":"Int J Cancer"},{"key":"B153","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver\u2019s seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1177\/1078155218771152","article-title":"Do proton pump inhibitors modulate the efficacy of anti-PD-1\/PD-L1 therapy? A retrospective study","volume":"25","author":"Mukherjee","year":"2019","journal-title":"J Oncol Pharm Pract: Off Publ Int Soc Oncol Pharm Practitioners"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e14092","article-title":"Proton pump inhibitors and response to immune check-point inhibitors: Single center study","volume":"37","author":"Trabolsi","year":"2019","journal-title":"J Clin Oncol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ctm2.37","article-title":"Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints","volume":"10","author":"Hargadon","year":"2020","journal-title":"Clin Trans Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0140-9","article-title":"Metabolic interventions in the immune response to cancer","volume":"19","author":"O\u2019Sullivan","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3642","article-title":"Intratumoral Immunotherapy for Early-stage Solid Tumors","volume":"26","author":"Hong","year":"2020","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118841","article-title":"Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy","volume":"575","author":"Fang","year":"2020","journal-title":"Int J Pharmaceutics"},{"key":"B165","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40170-017-0168-x","article-title":"Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities","volume":"5","author":"Lanning","year":"2017","journal-title":"Cancer Metab"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00428","article-title":"Metabolic Reprogramming in Triple-Negative Breast Cancer","volume":"10","author":"Sun","year":"2020","journal-title":"Front Oncol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102438","article-title":"BRCA1 induces major energetic metabolism reprogramming in breast cancer cells","volume":"9","author":"Privat","year":"2014","journal-title":"PLoS One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9732","article-title":"Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based \u201cstarvation\u201d strategies in BRCA1 carriers","volume":"7","author":"Cuyas","year":"2016","journal-title":"Oncotarget"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, Metabolism, and Cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discovery"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3390\/jcm8111811","article-title":"Genes and Variants Underlying Human Congenital Lactic Acidosis-From Genetics to Personalized Treatment","volume":"8","author":"Bravo-Alonso","year":"2019","journal-title":"J Clin Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0817-3","article-title":"The miR-186-3p\/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells","volume":"38","author":"He","year":"2019","journal-title":"Oncogene"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1210\/en.2019-00097","article-title":"Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis","volume":"160","author":"Blundon","year":"2019","journal-title":"Endocrinology"},{"key":"B173","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tem.2018.10.006","article-title":"Crosstalk between Estrogen Signaling and Breast Cancer Metabolism","volume":"30","author":"Kulkoyluoglu-Cotul","year":"2019","journal-title":"Trends Endocrinol Metab: TEM"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00245","article-title":"Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy","volume":"10","author":"Rani","year":"2019","journal-title":"Front Endocrinol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx137","article-title":"Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer","volume":"110","author":"Heindl","year":"2018","journal-title":"J Natl Cancer Institute"},{"key":"B176","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13058-019-1176-2","article-title":"Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes","volume":"21","author":"Sobral-Leite","year":"2019","journal-title":"Breast Cancer Res: BCR"},{"key":"B177","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41523-019-0133-7","article-title":"If we build it they will come: targeting the immune response to breast cancer","volume":"5","author":"Gatti-Mays","year":"2019","journal-title":"NPJ Breast Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.598626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T04:27:57Z","timestamp":1606364877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.598626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":177,"alternative-id":["10.3389\/fonc.2020.598626"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.598626","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"article-number":"598626"}}